SOPHiA GENETICS (SOPH) Cash from Investing Activities (2020 - 2025)

SOPHiA GENETICS has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$3.5 million for Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at -$3.5 million, down 178.02% year-over-year; the trailing twelve-month figure through Dec 2025 was -$8.7 million (down 82.33% YoY), and the FY2025 annual result was -$8.7 million, down 82.33% from the prior year.
• Cash from Investing Activities came in at -$3.5 million for Q4 2025 at SOPHiA GENETICS, down from -$2.6 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $18.0 million in Q2 2022 to a low of -$52.7 million in Q3 2021.
• The 5-year median for Cash from Investing Activities is -$1.2 million (2024), against an average of -$770550.0.
• Across the five-year window, Cash from Investing Activities plunged 7238.58% in 2021 and jumped 1044.1% in 2022, its largest moves.
• SOPHiA GENETICS's Cash from Investing Activities stood at -$1.3 million in 2021, then soared by 1043.12% to $12.1 million in 2022, then slumped by 80.18% to $2.4 million in 2023, then plunged by 152.37% to -$1.3 million in 2024, then sank by 178.02% to -$3.5 million in 2025.
• The last three Cash from Investing Activities figures came in at -$3.5 million (Q4 2025), -$2.6 million (Q3 2025), and -$1.6 million (Q2 2025), per Business Quant data.